VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
1.440
-0.440 (-23.40%)
At close: Apr 25, 2025, 4:00 PM
1.430
-0.010 (-0.69%)
After-hours: Apr 25, 2025, 4:01 PM EDT
VYNE Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VYNE Therapeutics stock have an average target of 6.25, with a low estimate of 4.50 and a high estimate of 8.00. The average target predicts an increase of 334.03% from the current stock price of 1.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VYNE Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.75 → $4.5 | Strong Buy | Maintains | $5.75 → $4.5 | +212.50% | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +299.31% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +299.31% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +299.31% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +299.31% | Jan 6, 2025 |
Financial Forecast
Revenue This Year
204.00K
from 501.00K
Decreased by -59.28%
Revenue Next Year
204.00K
from 204.00K
EPS This Year
-1.20
from -0.94
EPS Next Year
-1.06
from -1.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 420,000 | 420,000 | n/a | |
| Avg | 204,000 | 204,000 | n/a | |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -16.2% | 105.9% | - | |
| Avg | -59.3% | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.23 | -0.79 | -0.85 |
| Avg | -1.20 | -1.06 | -0.83 |
| Low | -1.16 | -1.29 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.